IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor

Clinical trial NCT00609141 · COMPLETED

Trial details

NCT number: NCT00609141
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2008-01-01
Primary completion: 2009-09-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.